Department of Trauma and Surgical Critical Care, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Hepato-biliary and Pancreas Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
J Hepatobiliary Pancreat Sci. 2017 Oct;24(10):550-558. doi: 10.1002/jhbp.495. Epub 2017 Sep 18.
In cases of acute cholecystitis (AC), postoperative antibiotic prophylaxis is generally used for the purpose of preventing subsequent infections. However, there is still no standardized guideline regarding antibiotic administration after cholecystectomy.
A total of 200 patients at five participating hospitals who were admitted for cholecystectomy to treat grade I or II AC were enrolled and randomly allocated to a group given a placebo (group A) or a group given postoperative antibiotics (group B). Surgical outcomes and incidence of postoperative infectious morbidities were reviewed.
A total of 188 patients (95 patients in group A and 93 patients in group B) were finally analyzed. The incidence rate of infectious complications (seven cases, 7.4%, in group A and eight cases, 8.6%, in group B, P = 0.794) and overall non-infectious complications (seven cases, 7.4%, in group A and six cases, 6.5%, in group B, P = 1.000) showed no significant difference between the two groups.
Absence of postoperative antibiotic administration did not lead to an increase in postoperative infections in cases of mild to moderate AC. Avoidance of unnecessary antibiotic use will reduce the adverse effects of antibiotics and also allow for a tailored treatment strategy according to the severity of cholecystitis.
在急性胆囊炎(AC)的情况下,通常会使用术后抗生素预防来预防后续感染。然而,胆囊切除术后抗生素使用仍没有标准化的指南。
共有 200 名在五家参与医院接受胆囊切除术治疗 I 级或 II 级 AC 的患者被纳入研究,并随机分配到接受安慰剂(A 组)或术后抗生素(B 组)的治疗组。评估手术结果和术后感染性并发症的发生率。
最终对 188 名患者(A 组 95 例,B 组 93 例)进行了分析。感染性并发症(A 组 7 例,7.4%;B 组 8 例,8.6%)和总体非感染性并发症(A 组 7 例,7.4%;B 组 6 例,6.5%)的发生率在两组之间没有显著差异。
在轻度至中度 AC 中,不使用术后抗生素治疗不会导致术后感染增加。避免不必要的抗生素使用将减少抗生素的不良反应,并根据胆囊炎的严重程度制定个体化的治疗策略。